COMMUNIQUÉS West-GlobeNewswire
-
EssilorLuxottica: Résultats T2/S1 2026 - Trajectoire solide du chiffre d’affaires à +9,7 % au S1, avec un T2 à +8,7 %. Rentabilité en hausse, avec un résultat opérationnel ajusté progressant de +15 %.
28/07/2026 -
North Texas Plastic Surgery’s Dr. Sacha Obaid Named to Newsweek’s America’s Best Plastic Surgeons 2025 List
28/07/2026 -
Colorectal Cancer Doesn’t Care How Young You Are
28/07/2026 -
Starget Pharma Expands Scientific Advisory Board with Appointment of Two Global Leaders in Radiopharmaceutical Therapy
28/07/2026 -
Corbus Pharmaceuticals Announces FDA Clearance to Initiate TEMPO-1 Registrational Study of CRB-701 in Patients with 2L Oropharyngeal Cancer
28/07/2026 -
Legend Biotech to Host Investor Conference Call on Second Quarter 2026 Results
28/07/2026 -
STRATA Skin Sciences Appoints Medical Device Commercial Leader Erica Jordan as Chief Executive Officer
28/07/2026 -
Apyx Medical Corporation to Participate in the Canaccord Genuity 46th Annual Growth Conference
28/07/2026 -
CorVascular Named Exclusive U.S. Importer and Vascular Distributor for ASUS FDA-Cleared Ultrasound Portfolio
28/07/2026 -
Firefly Neuroscience (NASDAQ: AIFF) and Next Health Launch Precision Cognitive Health Initiative as FDA Advisory Committee’s Recommendation Backs Broader Access to Key Neuroprotective Peptides
28/07/2026 -
Oak Hill Bio Announces Dosing of First Participant in BEACON Phase 3 Clinical Trial of Rugonersen in Angelman Syndrome
28/07/2026 -
Leap Distributors Levels Up: Names Dave Ascani CFO
28/07/2026 -
Applied Biologics Expands National Commercial Payer Engagement Strategy for XWRAP®
28/07/2026 -
Claris Bio Unveils Development Strategy, Planned Pivotal Study Supported by $118 Million Series B Financing from Top-Tier Investors, and Multiple Leadership Appointments
28/07/2026 -
Slate Medicines Establishes Clinical and Scientific Advisory Boards to Advance Next-Generation Migraine Prevention Therapeutics
28/07/2026 -
Pacira BioSciences Announces New National Survey Revealing the Hidden Toll of Pain on America’s Workforce
28/07/2026 -
Nautilus Biotechnology Reports Second Quarter 2026 Financial Results
28/07/2026 -
YD Bio Launches Cross-Border Cancer Testing Pilot with Numia Health to Evaluate Expanded Access to Molecular Diagnostics in Canada
28/07/2026 -
Standard BioTools Announces Sale of Mass Cytometry Business and Illumina’s Buyout of Contingent Payments to Advance Merger with Treeline Biosciences
28/07/2026
Pages